PHAR

Wall Street ends higher as investors eye U.S. midterms

Take-Two and Lyft collapse on pessimistic forecasts Amgen climbs on cholesterol drug data Indices: S&P 500 +0.56%, Nasdaq +0.49%, Dow +1.02% Nov 8 (Reuters) – Wall Street ended higher on Tuesday in the vote in the midterm elections that will determine control of the U.S. Congress, with investors betting on a political deadlock that could …

Wall Street ends higher as investors eye U.S. midterms Read More »

CVS, Walmart, Walgreens agree to pay $13.8 bln to settle U.S. opioid claims

Nov 2 (Reuters) – CVS Health Corp (CVS.N)Walgreens Boots Alliance Inc. (WBA.O) and Walmart Inc. (WMT.N) agreed to pay approximately $13.8 billion to resolve thousands of lawsuits filed by U.S. state, local and tribal governments accusing drugstore chains of mishandling opioid painkillers. CVS said Wednesday it agreed to pay about $5 billion over 10 years, …

CVS, Walmart, Walgreens agree to pay $13.8 bln to settle U.S. opioid claims Read More »

U.S. adds China’s YMTC and 30 other firms to ‘unverified’ trade list

WASHINGTON, Oct 7 (Reuters) – The United States on Friday added major Chinese memory chipmaker YMTC and 30 other Chinese entities to a list of companies that U.S. officials have been unable to inspect, saying which increased tensions with Beijing and launched a 60-day clock. this could result in much harsher penalties. The new listings …

U.S. adds China’s YMTC and 30 other firms to ‘unverified’ trade list Read More »

U.S. FDA green lights Omicron-targeted COVID boosters ahead of revaccination campaign

Join now for FREE unlimited access to Reuters.com Register Aug 31 (Reuters) – The U.S. Food and Drug Administration on Wednesday cleared Pfizer’s updated COVID-19 booster shots (PFE.N)/BioNTech (22UAy.DE) and Moderna that target the dominant BA.4 and BA.5 Omicron subvariants, as the government prepares for a massive fall vaccination campaign that could begin within days. …

U.S. FDA green lights Omicron-targeted COVID boosters ahead of revaccination campaign Read More »

Musk sends fresh letter to scrap Twitter deal after whistleblower claims

Join now for FREE unlimited access to Reuters.com Register Aug 30 (Reuters) – Elon Musk has sent an additional letter terminating the deal to Twitter Inc. (TWTR.N) to include a recent whistleblower complaint from the social media company’s former chief security officer as another reason to cancel the $44 billion deal. Peiter Zatko, a notorious …

Musk sends fresh letter to scrap Twitter deal after whistleblower claims Read More »

Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine

Moderna’s logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration Join now for FREE unlimited access to Reuters.com Register Aug 26 (Reuters) – Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 vaccine approved …

Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine Read More »

Bluebird’s $2.8 million gene therapy becomes most expensive drug after U.S. approval

Signage is seen outside the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Join now for FREE unlimited access to Reuters.com Register Aug 17 (Reuters) – The U.S. Food and Drug Administration on Wednesday approved Bluebird Bio’s (BLUE.O) gene therapy for patients with a rare disease …

Bluebird’s $2.8 million gene therapy becomes most expensive drug after U.S. approval Read More »